George Davis is a Cardiology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2101 Foulk Rd
Wilmington, DE 198104710
Telephone
302-475-8101Registry record last updated 28 Feb 2011.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BIOTRONIK INC.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20255 payments
- Novartis Pharmaceuticals CorporationProgram year202423 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81%Statin22.6%Rosuvastatin Calcium65%Atorvastatin Calcium25%Pravastatin Sodium6%Simvastatin3%Pitavastatin Calcium2%Part D<11 patientsBeta blocker19.5%Metoprolol Succinate41%Carvedilol21%Nebivolol Hcl18%Metoprolol Tartrate16%Atenolol4%Bisoprolol Fumarate1%Part D<11 patients+ 17 more classes in this area
Blood & clotting
15.8%Factor Xa inhibitor12.3%Eliquis86%Xarelto14%Part D≥124 patientsP2Y12 inhibitor2.8%Clopidogrel84%Brilinta17%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.2%Potassium supplement1.4%Potassium Chloride100%Part D≥22 patientsProton pump inhibitor0.8%Omeprazole67%Pantoprazole Sodium33%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2007–2012 per NIH RePORTER. The latest:
- Building Research Capacity for the 21st Century: an MBRS SCORE Proposal
Delaware State University
FY2010$61,022S06GM073765 - Building Research Capacity for the 21st Century: an MBRS SCORE Proposal
Delaware State University
FY2009$140,144S06GM073765
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”